Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
HEB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.67%176.001.2%$592.87m
CELGCelgene Corporation
0.00%89.201.2%$509.00m
BIIBBiogen Inc.
1.05%272.281.2%$467.20m
GILDGilead Sciences, Inc.
0.04%73.280.9%$411.00m
INCYIncyte Corporation
0.00%62.992.5%$245.54m
REGNRegeneron Pharmaceuticals, Inc.
0.00%316.172.7%$243.99m
VRTXVertex Pharmaceuticals Incorporated
-1.28%153.161.9%$217.79m
ALXNAlexion Pharmaceuticals, Inc.
8.07%114.602.0%$216.65m
ILMNIllumina, Inc.
0.00%231.193.5%$196.58m
NKTRNektar Therapeutics
0.15%82.716.0%$194.70m
AAgilent Technologies, Inc.
0.00%65.811.5%$162.73m
ALNYAlnylam Pharmaceuticals, Inc
0.00%94.339.8%$134.72m
BLUEBluebird Bio, Inc.
0.00%162.6015.8%$118.46m
EXASExact Sciences Corporation
1.17%45.8025.7%$111.25m
BMRNBioMarin Pharmaceutical Inc.
0.00%81.534.4%$101.49m

Company Profile

Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.